|
|
"A comprehensive, collaborative elections resource."
|
New FDA changes: Alli and Xenical
|
|---|
| Parent(s) |
Issue
|
| Contributor | Jason |
| Last Edited | Jason Jun 09, 2010 03:59am |
| Logged |
0
|
| Category | Rule Change |
| Author | Catherine O'Neill |
| News Date | Monday, June 7, 2010 09:00:00 AM UTC0:0 |
| Description | As if side effects of "oily spotting in your undergarments, gas with discharge, and inability to control bowel movements" aren't scary enough, the makers of Alli and Xenical have now revised their label to include a new risk: liver damage.
According to a recent FDA safety announcement, the makers of Alli and Xenical (different doses of the same drug, Orlistat) now must include information about the possible danger of severe liver damage with use. This was prompted after the FDA reviewed 13 reported cases of severe liver damaged linked to the active ingredient Orlistat (12 occurred with Xenical, 1 with Alli). The cases were relatively rare, yet severe, which is why consumers of the drug are now being told to be aware of the signs of possible liver problems (such as yellowing of the skin and eyes, not just your pants). |
| Share |
|
|
2¢
|
|
| Article | Read Full Article |
|
| Date |
Category |
Headline |
Article |
Contributor |
|
|
